The Journal of
Clinical Psychiatry

Schizophrenia/Schizoaffective Disorders

Letter to the Editor November 15, 2007

Reply to Aripiprazole and Perphenazine: No Difference

Robert D. McQuade; Ronald N. Marcus; Raymond Sanchez; Herbert Y. Meltzer; John M. Kane; William H. Carson, Jr.

J Clin Psychiatry 2007;68(11):1813-1814

Article Abstract

Letter to the Editor

About the Authors

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Read the Current Issue

Original Research

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Original Research

Valbenazine in Elderly Adults With Tardive Dyskinesia

Academic Highlights

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Original Research

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Consensus Statement

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Brief Report

Psychosocial Correlates of Optimism among US Military Veterans

View current Issue

Letter to the Editor

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the...

Xintong Mu, Hiroyoshi Takeuchi

Letter to the Editor

Asenapine, Aggression, and Affinity

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.

Rif S. El-Mallakh

Letter to the Editor

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.

Barbara Mintzes, Alain Braillon, Florian Naudet, et al

Reply to Aripiprazole and Perphenazine: No Difference

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

ELSEWHERE:

FOLLOW US:

Reply to Aripiprazole and Perphenazine: No Difference

About the Authors

Read the Current Issue

Incidence and Risk Factors for Suicide Attempt During Pregnancy and Postpartum

Valbenazine in Elderly Adults With Tardive Dyskinesia

Optimizing Treatment With Aripiprazole Monohydrate: Pharmacokinetic Advantages of Long-Acting Injectable Formulations, A Consensus Panel Report

Older Adults Visiting Emergency Departments for Mental Health Issues:A CHIRPP Database Study

Developing a Treatment-Resistant Depression Consultation Program, Part I: Practical and Logistical Considerations

Psychosocial Correlates of Optimism among US Military Veterans

Related Articles

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

Asenapine, Aggression, and Affinity

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles